Sex-related differences in ventricular remodeling after myocardial infarction.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 09 2021
Historique:
received: 11 02 2021
revised: 11 07 2021
accepted: 15 07 2021
pubmed: 28 7 2021
medline: 21 10 2021
entrez: 27 7 2021
Statut: ppublish

Résumé

The epidemiology, clinical features and outcome of myocardial infarction (MI) display significant differences between men and women. Prominent sex differences have also been suggested in left ventricular (LV) remodeling after MI. Ventricular remodeling refers to a deterioration of LV geometry and function often leading to heart failure (HF) development and an increased risk of adverse cardiovascular events. Women have a lower propensity to the acquisition of a spherical geometry and LV dysfunction. These differences can be attributed at least partially to a lower frequency of transmural infarction and smaller areas of microvascular obstruction in women, as well as to a less prominent activation of neuroendocrine systems and apoptotic, inflammatory and profibrotic pathways in women. Estrogens might play a role in this difference, which could partially persist even after the menopause because of a persisting intramyocardial synthesis of estrogens in women. Conversely, androgens may exert a detrimental influence. Future studies should better clarify sex differences in the predictors, clinical correlates, prognostic impact and disease mechanisms of remodeling, as well as the existence of sex-specific therapeutic targets. This research effort should hopefully allow to optimize the treatment of MI during the acute and post-acute phase, possibly through different therapeutic strategies in men and women, with the goal of reducing the risk of HF development and improving patient outcome.

Identifiants

pubmed: 34314766
pii: S0167-5273(21)01181-5
doi: 10.1016/j.ijcard.2021.07.036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

62-69

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Alberto Aimo (A)

Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy; Fondazione Toscana Gabriele Monasterio, Pisa, Italy. Electronic address: a.aimo@santannapisa.it.

Giorgia Panichella (G)

Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy.

Andrea Barison (A)

Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Silvia Maffei (S)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Matteo Cameli (M)

Department of Medical Biotechnologies, Section of Cardiology, University of Siena, Italy.

Stefano Coiro (S)

Division of Cardiology, University of Perugia, Italy.

Flavio D'Ascenzi (F)

Department of Medical Biotechnologies, Section of Cardiology, University of Siena, Italy.

Carlo Di Mario (C)

Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Riccardo Liga (R)

Cardio-Thoracic and Vascular Department, University Hospital, Pisa, Italy.

Rossella Marcucci (R)

Experimental and Clinical Medicine, University of Florence, Atherothrombotic Center, AOU Careggi, Florence, Italy.

Doralisa Morrone (D)

Cardio-Thoracic and Vascular Department, University Hospital, Pisa, Italy.

Iacopo Olivotto (I)

Cardiomiopathy Unit, AOU Careggi, Florence, Italy. Società Italiana di Cardiologia, Sezione Regionale Tosco-Umbra.

Isabella Tritto (I)

Division of Cardiology, University of Perugia, Italy.

Michele Emdin (M)

Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH